Recent Updates
Recently added Catalysts
MXCT Positive Sentiment

MaxCyte to Participate in Upcoming Investor Conferences

Thursday, June 1, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: MaxCyte, Inc. announces its participation in two upcoming investor conferences: the William Blair 43rd Annual Growth Stock Conference on June 8 and the TD Cowen 2nd Annual Tools/Dx Revolution on June 26. The company's management will engage with investors to discuss advancements in cell-engineering technologies. A webcast of the William Blair presentation will be made available on MaxCyte's investor relations website. This participation reflects MaxCyte's commitment to advancing cell-based research and therapeutic development.
Price reaction · baseline $4.08 (2023-05-31 close) · hit after-hours · clean, no other MXCT news in the window
day 0 close · peak
+1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in reputable investor conferences signals growth potential.
  • Opportunity for management to showcase advancements in cell-engineering.
  • Engagement with investors may enhance company visibility and financing.

Full Press Release Details

ROCKVILLE, Md., June 01, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today announced Company management will participate at the following investor conferences:
William Blair 43rd Annual Growth Stock Conference
Thursday, June 8 at 8:00 a.m. Central Time
TD Cowen 2nd Annual Tools/Dx Revolution
Monday, June 26th at 3:10 PM Pacific Time
A live and archived webcast of the William Blair Presentation will be available on the “Events” section of the MaxCyte investor relations website at https://investors.maxcyte.com/.
Spectrum Seismic Collaborative
valerie@spectrumscience.com
Nominated Adviser and Joint Corporate Broker
Emma Earl / Freddy Crossley

Frequently Asked Questions

What is MaxCyte, Inc. known for?

MaxCyte, Inc. specializes in cell-engineering technologies to enhance cell-based research.

When will MaxCyte present at the William Blair Conference?

MaxCyte will present at the William Blair Conference on June 8 at 8:00 a.m. CT.

Where can I access the webcast of MaxCyte's presentation?

The webcast can be found in the 'Events' section of MaxCyte's investor relations website.

When is MaxCyte participating in the TD Cowen Conference?

MaxCyte will participate in the TD Cowen Conference on June 26 at 3:10 PM PT.

ShareAdd on Google
Tags: MXCT Viatris Investor Conferences Healthcare MaxCyte cell-engineering investor conferences growth stock
Last updated: Jun 1, 2023

Biotech snapshot

Cash runway
$106M liquidity · $2M/mo burn
~67 mo
Minimal dilution risk